The Journal of Medical Sciences

Register      Login

VOLUME 6 , ISSUE 4 ( October-December, 2020 ) > List of Articles


Management of AKI in Rhino-sinosal Mucormycosis Treated with Amphotericin B

Srinivas M Prasad, MVS Shreyas, MS Prakash, S Santhosh

Keywords : COVID-19, Fungal infection, Hypervolemia

Citation Information : Prasad SM, Shreyas M, Prakash M, Santhosh S. Management of AKI in Rhino-sinosal Mucormycosis Treated with Amphotericin B. J Med Sci 2020; 6 (4):70-73.

DOI: 10.5005/jp-journals-10045-00161

License: CC BY-NC 4.0

Published Online: 30-11-2021

Copyright Statement:  Copyright © 2020; The Author(s).


We describe a case of rhino-sinosal mucormycosis in a CAT-B coronavirus disease-2019 (COVID-19) patient who developed an AKI, 2 weeks following her recovery from COVID-19. The case report explores the impact of appropriate fluid balance on the treatment of AKI in a patient receiving Inj amphotericin B for the management of rhino-sinosal mucormycosis which she contracted during her COVID-19 infection.

  1. Nadim MK, Forni LG, Mehta RL, et al. COVID-19-associated acute kidney injury: consensus report of the 25th acute disease quality initiative (ADQI) workgroup. Nat Rev Nephrol 2020;16(12):747–764. DOI: 10.1038/s41581-020-00356-5.
  2. Takazono T, Tashiro M, Ota Y, et al. Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan. Sci Rep 2020;10(1):15033. DOI: 10.1038/s41598-020-72135-y.
  3. Ostermann M, Straaten HM, Forni LG. Fluid overload and acute kidney injury: cause or consequence? Crit Care 2015;19(1):443. DOI: 10.1186/s13054-015-1163-7.
  4. Maini A, Tomar G, Khanna D, et al. Sino-orbital mucormycosis in a COVID-19 patient: a case report. Int J Surg Case Rep 2021;82:105957. DOI: 10.1016/j.ijscr.2021.105957.
  5. Garg D, Muthu V, Sehgal IS, et al. Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia 2021;186(2):289–298. DOI: 10.1007/s11046-021-00528-2.
  6. Gupta KL, Gupta A. Mucormycosis and acute kidney injury. J Nephropathol 2012;1(3):155–159. DOI: 10.5812/nephropathol. 8111.
  7. Hernández JL, Buckley CJ. Mucormycosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
  8. Weerakkody Y. Sinonasal mucormycosis: radiology reference article. Radiopaedia Blog RSS 2016 (accessed August 22, 2021).
  9. Armstrong-James D, Koh M, Ostermann M, et al. Optimal management of acute kidney injury in critically ill patients with invasive fungal infections being treated with liposomal amphotericin B. BMJ Case Rep 2020;13(5):e233072. DOI: 10.1136/bcr-2019-233072.
  10. Mistro S, Maciel Ide M, de Menezes RG, et al. Does lipid emulsion reduce amphotericin B nephrotoxicity? a systematic review and meta-analysis. Clin Infect Dis 2012;54(12):1774–1777. DOI: 10.1093/cid/cis290.
  11. Raimundo M, Crichton S, Martin JR, et al. Increased fluid administration after early acute kidney injury is associated with less renal recovery. Shock 2015;44(5):431–437. DOI: 10.1097/SHK.0000000000000453.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.